Article Details

FLX Bio Adds Distinguished Biopharma Industry Leader Michael Giordano, MD, to Board of Directors

Retrieved on: 2018-02-04 21:06:53

Tags for this article:

Click the tags to see associated articles and topics

FLX Bio Adds Distinguished Biopharma Industry Leader Michael Giordano, MD, to Board of Directors. View article details on hiswai:

Excerpt

<div>Located in South San Francisco, Calif., and funded by leading investors, including The Column Group (TCG), Kleiner Perkins (KP), Topspin Partners, GV (formerly <b>Google Ventures</b>) and Celgene Corporation, FLX Bio has assembled a leadership team and advisory group with a proven track record of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up